Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-15
2011-03-15
Loewe, Sun Jae Y. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S531000
Reexamination Certificate
active
07906549
ABSTRACT:
The present invention relates to a compound represented by the formula (I), a salt thereof, an N-oxide form thereof, a solvate thereof, or a prodrug thereof, and a medicament containing the same. The compound represented by the formula (I) has an ability to bind to an S1P receptor (particularly, EDG-1, EDG-6, and/or EDG-8) and is useful for preventing and/or treating for rejection to transplantation, graft-versus-host disease, autoimmune diseases, allergic diseases, neurodegenerating diseases, and the like.wherein all symbols are described in the specification.
REFERENCES:
patent: 5618843 (1997-04-01), Fisher et al.
patent: 5789595 (1998-08-01), Kohama et al.
patent: 6818774 (2004-11-01), Cesura et al.
patent: 7060697 (2006-06-01), Marsilje et al.
patent: 7351725 (2008-04-01), Doherty et al.
patent: 7381719 (2008-06-01), Blanco-Pillado et al.
patent: 2002/0072518 (2002-06-01), Khanna et al.
patent: 2003/0139597 (2003-07-01), Xue et al.
patent: 2004/0058894 (2004-03-01), Doherty et al.
patent: 2004/0224941 (2004-11-01), Seko et al.
patent: 2007/0167425 (2007-07-01), Nakade et al.
patent: 2472715 (2003-07-01), None
patent: 0635492 (1995-01-01), None
patent: 96/13497 (1996-05-01), None
patent: 98/38156 (1998-09-01), None
patent: 01/21577 (2001-03-01), None
patent: 02/18377 (2002-03-01), None
patent: 02/092068 (2002-11-01), None
patent: 03/061567 (2003-07-01), None
patent: 03/062248 (2003-07-01), None
patent: 03/062252 (2003-07-01), None
patent: 03/091219 (2003-11-01), None
patent: 2004/026305 (2004-04-01), None
patent: 2004/113330 (2004-12-01), None
patent: 2005/020882 (2005-03-01), None
Chawla et al., “Challenges in Polymorphism of Pharmaceuticals”, CRIPS vol. 5, No. 1, Jan.-Mar. 2004 (**4 Pages**.
Newman et al., “Solid-state analysis of the active pharmaceutical ingredient in drug products”, DDT vol. 8, No. 19, Oct. 2003, p. 898-905.
Nakade et al., caplus an 2005:216595.
Russian Office Action dated Oct. 9, 2009 in Application No. 2007126654.
M.D. Mashkovsky, “Lekarstvennie Sredstva,” Moskva, vol. 1, p. 8 (1993).
“Khimicheskii Enciklopedicheskii Slovar,” Moskva, “Sovetskaya Enciklopediya,” pp. 130-131 (1983).
Matthew J. Fisher et al., “Dihydroisoquinolone RGD Mimics. Exploration of the Aspartate Isostere”, Bioorganic & Medicinal Chemistry Letters, 1997, pp. 2537-2542, vol. 7, No. 19.
Ai Yu Shen et al., “Cytotoxicity and Antimicrobial Activity of Some Naphthol Derivatives”, Arch. Pharm., 1995, pp. 197-201, 328.
Anthony R. West., “Solid State Chemistry and Its Applications”, 1988, pp. 358 and 365, Wiley, New York.
Chinese Office Action issued in counterpart Chinese Application No. 200580048066.7, dated May 27, 2010.
Russian Office Action issued in counterpart Russian Application No. 2007126654, dated May 27, 2010.
Office Action from the Australian Government IP dated Aug. 31, 2010, issued in counterpart Australian Patent Application No. 2005314938.
Examination Report dated Aug. 17, 2010, issued by the Intellectual Property Office of New Zealand in counterpart New Zealand Application No. 555810.
Habashita Hiromu
Kurata Haruto
Nakade Shinji
Loewe Sun Jae Y.
Ono Pharmaceutical Co. Ltd.
Sughrue & Mion, PLLC
LandOfFree
Aminocarboxylic acid derivative and medicinal use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminocarboxylic acid derivative and medicinal use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminocarboxylic acid derivative and medicinal use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2727723